Skip to content

Evaluation of effects of hydrocortisone on prevention of post spinal headache

Evaluation of prophylactic effects of intravenous hydrocortisone on incidence and severity of post dural puncture headache after spinal anesthesia in comparison to control group

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014071216415N4
Enrollment
70
Registered
2014-07-17
Start date
2014-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-dural puncture headache. Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified

Interventions

Intervention 1: Intervention: Prescription of intravenous hydrocortison 5 mg/kg. Intervention 2: Control group: Normal saline as a placebo.
Treatment - Drugs
Intervention: Prescription of intravenous hydrocortison 5 mg/kg
Control group: Normal saline as a placebo

Sponsors

Deputy of Research and technology of Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 15 to 65 years old; ASA 1 and 2; candidates of lower extremity or lower abdominal surgeries under spinal anesthesia; no history of migraine headache; no history of prescription of steroidal or non-steroidal anti-inflammatory drugs; without opiate addiction Exclusion criteria: Failure of spinal anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Headache. Timepoint: 2; 6; 12 and 48 hours after surgery. Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Nausea and Vomitting. Timepoint: 2; 6; 24 and 48 after surgery. Method of measurement: Visual Analog Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolparvar M MD

Isfahan University of Medical Sciences

golparvar@med.mui.ac.ir+98 31 3624 9031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026